The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening

Area of Science:

• Cardiology
• Infectious Diseases
• Immunology

Background:

• Coronary artery disease (CAD) is a known comorbidity in individuals with human immunodeficiency virus (HIV) infection.
• The link between HIV and CAD is primarily driven by persistent inflammation from viremia and immune system dysregulation.
• Current clinical management and screening guidelines for CAD in HIV-infected populations remain insufficient.

Discussion:

• This editorial examines recent findings indicating that HIV-infected patients with abnormal cardiovascular stress tests are more prone to undergoing percutaneous coronary intervention (PCI).
• It delves into the cardiovascular sequelae of HIV infection.
• The discussion highlights potential clinical implications for managing these patients.

Key Insights:

• HIV-infected individuals with abnormal cardiac stress test results have an increased likelihood of subsequent percutaneous coronary intervention.
• Understanding the specific cardiovascular risks associated with HIV is crucial for effective patient management.
• There is a clear need for enhanced clinical strategies and evidence-based guidelines for CAD screening and treatment in the context of HIV.

Outlook:

• Further research is needed to establish definitive clinical management and screening protocols for CAD in HIV-infected patients.
• Investigating the long-term outcomes of PCI in this patient group will be essential.
• Developing targeted interventions to mitigate cardiovascular risk in HIV is a priority.